Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the LiteratureFelice Crocetto, Giuseppe Di Lorenzo, Erika Di Zazzo et al.|Nutrients|2021Cited by 68
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumorMatteo Ferro, Carlo Buonerba, Giuseppe Di Lorenzo et al.|World Journal of Urology|2019Cited by 62
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors aloneFelice Crocetto, Giuseppe Di Lorenzo, Matteo Ferro et al.|Critical Reviews in Oncology/Hematology|2023Cited by 36
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideGiuseppe Di Lorenzo, Carlo Buonerba, Dario Ribera et al.|Clinical Genitourinary Cancer|2021Cited by 23
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional AnalysisMatteo Ferro, Carlo Buonerba, Ottavio De Cobelli et al.|Frontiers in Oncology|2021Cited by 17